Cargando…

Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections

Iron is essential for multiple bacterial processes and is thus required for host colonization and infection. The antimicrobial activity of multiple iron chelators and gallium-based therapies against different bacterial species has been characterized in preclinical studies. In this review, we provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinuesa, Víctor, McConnell, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000330/ https://www.ncbi.nlm.nih.gov/pubmed/33809032 http://dx.doi.org/10.3390/ijms22062876

Ejemplares similares

Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii
por: Vinuesa, Víctor, et al.
Publicado: (2021)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017)

Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy
por: Wu, Ze-Liang, et al.
Publicado: (2020)

Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
por: Tsionou, Maria Iris, et al.
Publicado: (2017)

Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
por: Davey, Patrick R. W. J., et al.
Publicado: (2022)

Iron‐Gallium and Cobalt‐Gallium Tetraphosphido Complexes
por: Ziegler, Christoph G. P., et al.
Publicado: (2020)

Bacterial Resistance in Pneumonia in Developing Countries—A Role for Iron Chelation
por: Islam, Sufia, et al.
Publicado: (2019)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
por: Allan, David S., et al.
Publicado: (2022)

Advances in iron chelation therapy: transitioning to a new oral formulation
por: Shah, Nirmish R.
Publicado: (2017)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Recent Advances in Zirconium-89 Chelator Development
por: Bhatt, Nikunj B., et al.
Publicado: (2018)

Giving identity to the faceless threat of antibiotic resistance
por: McConnell, John
Publicado: (2004)

Adherence to Iron Chelation Therapy and Its Determinants
por: Sidhu, Sukhmani, et al.
Publicado: (2021)

Advancement of Gallium and Gallium-Based Compounds as Antimicrobial Agents
por: Li, Fupeng, et al.
Publicado: (2022)

Fusarinine C, a novel siderophore‐based bifunctional chelator for radiolabeling with Gallium‐68
por: Zhai, Chuangyan, et al.
Publicado: (2015)

Recent Advances on Gallium-Modified ZSM-5 for Conversion of Light Hydrocarbons
por: Feng, Zhe, et al.
Publicado: (2021)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
por: Chhabra, Ravneet, et al.
Publicado: (2020)

Bacterial Infections, Antimicrobial Resistance and Antibiotic Therapy
por: Kolář, Milan
Publicado: (2022)

Recent developments in detection and therapeutic approaches for antibiotic-resistant bacterial infections
por: Moorthy, Kavya, et al.
Publicado: (2023)

Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
por: Wang, Yuchuan, et al.
Publicado: (2019)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG
por: Cahill, Christina, et al.
Publicado: (2021)

Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling
por: Vágner, Adrienn, et al.
Publicado: (2018)

Regional siderosis: a new challenge for iron chelation therapy
por: Cabantchik, Zvi Ioav, et al.
Publicado: (2013)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
por: Nuñez, Marco T., et al.
Publicado: (2018)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_opuvpacfqvg3vjin9hif7k0g1m